Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05110963 · ClinicalTrials.gov registry record · NA
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
A NA study of HIV I Infection, sponsored by University of Connecticut.
- Active
- Registry status
- NA
- Development phase
- 3,771
- Enrollment target
- 2
- Study locations
NCT05110963 is a NA study of HIV I Infection that is active but no longer recruiting, run by University of Connecticut. The registered enrollment target is 3,771 participants, above the 1,350-participant average among 5 other HIV I Infection trials with a reported enrollment target (179% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT05110963, a NA study of HIV I Infection, is active but no longer recruiting, sponsored by University of Connecticut.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,771 participants
- Enrollment target
- 2
- Study locations
Study Summary
Retention in care and persistent adherence to antiretroviral therapy are necessary for the successful treatment of HIV infection. HIV-related stigma is a known impediment to the care and health outcomes of people living with HIV. The proposed study will test theory-based interventions designed to manage HIV stigma in order to improve care retention and medication adherence in communities with high-levels of HIV-related stigma.
Conditions Studied
Interventions
- BEHAVIORAL Uniform Standard of Care Counseling
- BEHAVIORAL Behavioral Self-Regulation Skills Counseling
- BEHAVIORAL Behavioral Self-Regulation Skills Counseling + Stigma Management
Study Locations (2)
Connecticut
- University of Connecticut - Storrs
Georgia
- University of Connecticut Field Site - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,771 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05110963
The ClinicalTrials.gov registry entry for NCT05110963 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3,771 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,350-participant average among 5 other HIV I Infection trials with a reported enrollment target (179% higher). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV I Infection appearing as the primary indexed condition, and to 3 interventions - of which Uniform Standard of Care Counseling is the first listed.
NCT05110963 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Georgia.
Frequently Asked Questions
What is clinical trial NCT05110963 about?
NCT05110963 is a clinical study titled "Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments". Retention in care and persistent adherence to antiretroviral therapy are necessary for the successful treatment of HIV infection. HIV-related stigma is a known impediment to the care and health outcomes of people living with HIV. The proposed study will test theory-based interventions designed to ma...
What is the current status of trial NCT05110963?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,771 participants. The study started on 2021-02-01. Estimated completion is 2026-11-01.
What conditions does trial NCT05110963 study?
This clinical trial studies the following conditions: HIV I Infection.
What interventions are being tested in trial NCT05110963?
The interventions under investigation include: Uniform Standard of Care Counseling (BEHAVIORAL), Behavioral Self-Regulation Skills Counseling (BEHAVIORAL), Behavioral Self-Regulation Skills Counseling + Stigma Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT05110963?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05110963 being conducted?
This trial has 2 study locations across Connecticut, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV I Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acute Effects of TCIG vs ECIG in PLWH
COMPLETED · NA
-
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
COMPLETED · Phase 1
-
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
COMPLETED · Phase 1
-
Charlotte Retention in Care Study
COMPLETED
-
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.